Skip to content
Sign in
Artwork for Dr. John Campbell
EducationHealth & FitnessMedicine

Dr. John Campbell

Campbellteaching

Hello Everyone, My name is John Campbell and I am a retired Nurse Teacher and former clinical nurse based in England. I also do some teaching in Asia and Africa when time permits. These videos are to help students to learn the background to all forms of health care. My PhD focused on the development of open learning resources for nurses nationally and internationally. LinkedIn profile, https://www.linkedin.com/in/dr-john-campbell-5256223b/ Twitter, https://twitter.com/Johnincarlisle Disclaimer; These media including videos, book, e book, articles, podcasts are not peer-reviewed. They should never replace individual clinical judgement from your own health care provider. No media-based material on this channel is suitable for using as professional medical advice. All comments are also for educational purposed only and must never replace advice from your own health care provider

Play
Open in
  • 790 episodes
  • daily
  • Avg 24 min
  • English

Episodes 790

NewestOldestLongest
All20Unplayed20In progress0Played0
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • October 16 · 33 min

    Science reveals less severe omicron disease

    Omicron symptoms, Headache, Fatigue, Runny nose, Sore throat, Sneezing https://www.youtube.com/watch?v=WH7ISb-ReAo https://covid.joinzoe.com Fever, cough, anosmia less common Headache, 65% Fatigue, 65% Runny nose, 65% Sore throat, 57% Sneezing, 55% The Australia experiment https://www.reuters.com/business/healthcare-pharmaceuticals/australia-push-ahead-with-reopening-amid-record-covid-19-cases-2022-01-03/?utm_source=Sailthru&utm_medium=email&utm_term=The%20Reuters%20Daily%20Briefing&utm_content=3-1-21&utm_campaign=3-1-21 Record infections Plans to reopen economy Prime Minister Scott Morrison We have to stop thinking about case numbers and think about serious illness, living with the virus, managing our own health and ensuring that we're monitoring those symptoms and we keep our economy going https://www.theguardian.com/australia-news/2022/jan/03/all-of-us-are-going-to-be-exposed-to-omicron-queensland-chief-health-officer-warns Queensland, chief health officer, Dr John Gerrard Omicron, peak at very large numbers in late January or early February We are expecting in the next few weeks very substantial numbers of people are going to be infected I think we just have to assume that all of us are going to be exposed in the next few weeks we can expect very large numbers of cases and in the majority of cases, the vast majority of cases, the symptoms will be mild So clearly the vaccine is working Queensland premier, Annastacia Palaszczuk What we’re doing is telling people to go and get vaccinated. We have … given every Queenslander in this state the opportunity to get vaccinated I’m now urging people in those Indigenous communities to ignore those social media posts and immediately go and get your vaccination SARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo https://www.researchsquare.com/article/rs-1189219/v1 Omicron infects and multiplies 70 times faster than the Delta in human bronchus Omicron variant replicated 10 times less in human lung tissue than the original SARS-CoV-2 virus SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19 https://www.biorxiv.org/content/10.1101/2021.12.26.474085v2 Mice infected with Delta compared to mice infected with Omicron Less severe clinical signs (weight loss) Lower virus loads Less extensive inflammation in the lungs T cell epitopes probably conserved Clinical consequences of infection with the Omicron variant may be less severe, but the higher transmissibility could still place huge burden upon healthcare systems The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters https://www.biorxiv.org/content/10.1101/2021.12.24.474086v1 All other SARS-CoV-2 VoCs replicate efficiently in Syrian hamsters In hamsters that had been infected with omicron, a 3 log10 lower viral RNA load was detected in the lungs No infectious virus was detectable in the lungs Histopathological examination, lungs from omicron-infected hamsters, no signs pneumonia. The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters https://www.researchsquare.com/article/rs-1211792/v1 B.1.1.529 Omicron isolates Immunocompetent and human ACE2 (hACE2) Expressing mice and hamsters Attenuated lung disease Not as ill Lower viral loads SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells https://www.embopress.org/doi/full/10.15252/embj.20105114 The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism https://www.gla.ac.uk/researchinstitutes/iii/cvr/engage/news/headline_829358_en.html https://www.gla.ac.uk/media/Media_829360_smxx.pdf Omi Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 23 min

    Cases down, long covid concerns

    Symptomatic cases, UK Uploaded 08-05-22 https://covid.joinzoe.com/data https://www.youtube.com/watch?v=8JqdsQcvgL8 https://covid.joinzoe.com/post/covid-numbers-tumble Down 27 % on the week Government figures 10 times lower UK R-value = 0.8 England, 0.8 Wales, 0.9 Scotland, 0.9. One in 27 people in the UK currently symptomatic BA.1 BA.2 symptoms BA.2 probably generate more mild symptoms BA.2 lower severity XE, not currently a big concern ONS https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsurveytechnicalarticlecumulativeincidenceofthenumberofpeoplewhohavetestedpositiveforcovid19uk/22april2022 Cumulative percentage, tested positive, survey N = 535,116 27th April 2020 to 11th February 2022 70.7% in England (38.5 million people) 56.0% in Wales (1.7 million people) 72.2% in Northern Ireland (1.3 million people) 51.5% in Scotland (2.7 million people) Risk of reinfection 10 times higher in Omicron times (20 December 2021 to 20 March 2022) Compared with the period when the Delta variant was most common (17 May to 19 December 2021). Risk of death Risk of death involving Omicron variant was 67% lower than the Delta variant of COVID-19 Antibodies Self-reported long COVID 1.8 million people (2.8% of the population) As of 3 April 2022 73% symptoms at least 12 weeks 44% at least one year Features Fatigue, 51% Shortness of breath, 33% Loss of sense of smell, 26% Difficulty concentrating, 23% Symptoms adversely affected the day-to-day activities, 67%) In double-vaccinated people Self-reported long COVID was almost twice as common after Delta than after Omicron BA.1 infections Antibody levels https://blog.ons.gov.uk/2021/04/28/antibodies-and-immunity-how-do-they-relate-to-one-another/ At or above the 179 ng/ml (16 and older) 98.8% in England 98.7% in Wales 99.0% in Northern Ireland 98.9% in Scotland Antibody level of 800 ng/ml 95.4% in England 95.6% in Wales 94.4% in Northern Ireland 94.7% in Scotland Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 8 min

    Australia omicron and immunization

    Special report on omicron and vaccination in Australia. Thanks as always to Dr. Nigel Farrier Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 28 min

    Booster troubles in vascular surgery

    Professor Sherif Sultan, MB BCh MCh MD FRCSI DEVS FISVS FASA DMD FRCS/Vasc EBQS/Vasc FAARM FACS FEVBS PhD Professor of Vascular & Endovascular Surgery National University of Ireland Chief of Vascular & Endovascular Surgery at The Galway Clinic Chairman of Western Vascular Institute President of International Society for Vascular Surgery University Hospital Galway NUIG & The Galway Clinic https://acrobat.adobe.com/id/urn:aaid:sc:EU:ea3bf115-1a02-4440-a153-6ec0149f258a https://acrobat.adobe.com/id/urn:aaid:sc:EU:95fadfe1-88d4-4708-8729-ef38596cdcee https://acrobat.adobe.com/id/urn:aaid:sc:EU:a4572ad8-0375-4aa7-a6a7-b9ad0a8d78ca https://acrobat.adobe.com/id/urn:aaid:sc:EU:8a9f87d0-e9a3-4af5-9675-d9dfe4f91e28 https://acrobat.adobe.com/id/urn:aaid:sc:EU:779ab225-f4bf-4757-a540-62e7036c3fef https://acrobat.adobe.com/id/urn:aaid:sc:EU:893d701f-acd0-4f03-bba3-1a8e0ca8fc2e Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 15 min

    Biowarfare

    With professor Paul Goddard. This link will take you to Profiteering From Doom on Amazon https://www.amazon.co.uk/dp/B0FWRRWTRH Uploaded 21-12-25 and this will take you to Profiteering From Doom on Shopify: https://www.clinicalpress.co.uk/products/profiteering-from-doom-just-follow-the-money www.clinical press.co.uk takes you to The Death Science on Shopify and the customer clicks on Shop for Books for all the other books For the guitars try: https://drjazzguitars.com Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 18 min

    Cancer treatment basics

    Professor of Oncology, Angus Dalgleish gives vital information on a repurposed drug he uses for his cancer patients, given at a very low dose. This is Low Dose Naltrexone. Uploaded 10-06-25 Check out the LDN trust website for much more, https://ldnresearchtrust.org Naltrexone at low doses (LDN) and its relevance to cancer therapy https://openaccess.sgul.ac.uk/id/eprint/114135/ Naltrexone was designed to inhibit opioid receptors without activating them and hence used to block the stimulatory effects of morphine and heroin. It was noted that in certain patients being treated with naltrexone for an opioid addiction many reported significant secondary benefit when being weaned off naltrexone. This group of patients had chronic inflammatory and autoimmune conditions and reported improvements whilst using the lower dosages of naltrexone. There have also been recent anecdotal reports of cancer resolution following the use of low doses of naltrexone (LDN). However, the mechanism of action is unclear. Areas covered We review three mechanisms through which LDN can influence cancer progression; namely, (a) antagonism of receptors to which LDN binds, which include toll-like receptors 7–9 that lead to IL-6 suppression b) modulation of immune function in patients; and c) direct inhibition of signaling pathways involved in cancer cell control, including the priming of pro-apoptotic pathways. Expert opinion Considering the increase in the number of anecdotal reports of activity, there will likely be a bigger drive toward using LDN in the oncological setting. These reports support clinical trials of LDN in cancer, especially when given in combination with certain chemotherapy. https://ldnresearchtrust.org/angus-dalgleish-md-role-ldn-management-cancer-2018-conference-ldn-low-dose-naltrexone Major clinical evidence on the use of low-dose naltrexone in the treatment of cancer: a systematic review https://www.researchgate.net/publication/384236060_Major_clinical_evidence_on_the_use_of_low-dose_naltrexone_in_the_treatment_of_cancer_a_systematic_review https://www.tandfonline.com/doi/full/10.1080/14737140.2022.2037426#abstract Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 21 min

    One million US deaths

    US, 1 million deaths this week, 100 million cases this fall and winter Uploaded 10-05-22 1918 / 1919 At least 50 million worldwide 675,000 in the United States (Population 105 million) Mortality was high in Younger than 5 years old 20-40 years old 65 years and older National Center for Health Statistics https://www.cdc.gov/nchs/index.htm More than 1 million deaths Higher death rate than in any other major industrialized country https://www.medrxiv.org/content/medrxiv/early/2022/02/24/2022.02.23.22271380.full.pdf Life expectancy, biggest drop since 1918 https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e2.htm Overwhelmingly unvaccinated Mostly old, low income, Black, Hispanic 2020 Heart disease, cancer, Covid Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States (Pen State) https://www.pnas.org/doi/10.1073/pnas.2007476117 9 million who have lost a close relative Grandparent, parent, sibling, spouse, child US cases / infections Probably start to go down from late May BA.2.12.1 subvariant set to overtake BA.2 Cases may increase in the South over summer Biden administration 100 million infections fall and winter 2022 Waning immunity, vaccines and infections Variant immune escape Loosened restrictions Projections assume omicron and subvariants will continue to dominate community spread No dramatically different strain of the virus Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm Convenience sample of blood specimens, for anti-N antibodies As of February 2022 18 to 49 years, 63.7% 50 to 64 years, 49.8% Over 65s, 33.2% Children and adolescents 75% of had serologic evidence of previous infection High infection rate for Omicron, especially among children. Should not be interpreted as protection from future infection Vaccination remains the safest strategy for preventing complications from SARS-CoV-2 infection COVID-19 Results Briefing, United States of America, April 7, 2022 https://www.healthdata.org/sites/default/files/files/Projects/COVID/2022/102_briefing_United_States_of_America_3.pdf 76% of people in the US have been infected at least once as of April 4 Do not suggest a substantial BA.2 surge in the US But if we do, last for 3 weeks There is not sufficient evidence at this time that BA.2 spread warrants a broader push on a fourth booster, except in those at high risk. Pfizer and Moderna Working on new booster shots Combine different variants of the virus Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 1 hr 6 min

    VAERS data with Dr Jessica Rose

    Links to more material from Jessica, https://jessicasuniverse.com https://jessicar.substack.com https://jessica5b3.substack.com @JessLovesMJK Uploaded 09-10-23 Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 9 min

    A threatening phone call

    ‘a threatening phone call’ https://www.telegraph.co.uk/news/2023/11/08/how-astrazeneca-vaccine-was-shelved/ Uploaded 07-01-24 8th November 2023 In March 2021, The Telegraph was one of the first newspapers to imply a causal link between the jab and blood clots after Norwegian scientists suggested a possible mechanism. On the day we published the story we received a threatening phone call from a senior official at the MHRA warning that The Telegraph would be banned from future briefings and press notices if we did not soften the news. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency From FDA to MHRA: are drug regulators for hire? https://www.bmj.com/content/377/bmj.o1538 June 2022 Industry money saturates the globe’s leading regulators. The BMJ found that the majority of regulators’ budget—particularly the portion focused on drugs—is derived from industry fees Another well-known Cambridge academic got in touch to complain about our “disgraceful fear-mongering headline” on the story, claiming that it would discourage vaccine uptake and cost lives. We politely pointed out that hiding the facts from people was not helpful and could also cost lives. The academic did not respond. In February this year, TikTok removed an audio clip in which I discussed whether the benefit of vaccination was worth the risks for young people, claiming it had breached community guidelines. After we showed that the Government’s own website acknowledges the link, the clip was reinstated. All of this shows a troubling paternalism in government, academia and some media outlets who believe that the public is not capable of weighing up the pros and cons of medical interventions and so must be shielded from the truth. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 35 min

    Winter hospitalisations will increase

    Eight-week scenarios for daily hospital admissions in England Uploaded 15-09-21 R = 1.1 – green, (is much more possible through a range of many different situations) R = 1.5 – blue (also likely) R = 2.0 – red (a possible outcome, but highly unlikely) https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1017676/2021-09-14_COVID-19_Press_Conference_Slides__for_publication_.pdf Hospitalisations likely to rise, 2,000 to 7,000 per day next month https://www.bbc.co.uk/news/uk-58566235 Government's Plan B if the NHS faced unsustainable pressure Sir Patrick Vallance When you make a move, you have to go earlier than you think you want to, you have to go harder than you think you want to and you have to make sure you have got the right geographical coverage SPI-M-O: Consensus Statement on COVID-19 (SAGE) https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1017129/S1376_SPI-M-O_Consensus_Statement.pdf Scientific Pandemic Influenza Group on Modelling (SPI-M) The UK is currently experiencing high prevalence and likely entering a period of growth A time of significant uncertainty School holidays Possibility for further evidence to emerge on the duration of immunity against COVID-19 Possibly broader, longer peaks than those originally estimated Potential for another large wave of hospitalisations Increasing cases remain the earliest warning sign that hospital admissions are likely to rise Clear consensus that continued high levels of homeworking has played a very important role in preventing sustained epidemic growth Highly likely that a significant decrease in homeworking in the next few months would result in a rapid increase in hospital admissions If enacted early enough, a relatively light set of measures could be sufficient to curb sustained growth Current epidemic estimates UK (Health Security Agency) R in England is between 0.9 and 1.1 Growth rate is between -1% and +1% per day It is unclear how high prevalence and admissions may go without intervention. Reflections on modelling Step 4 of the Roadmap After step 4 of the Roadmap on 19th July Factors Schools closed for summer Changes in behaviour Changes in mixing patterns have been more gradual the population has not reduced their cautious behaviours as dramatically as was considered possible Warm weather More sunshine Large proportion of the population isolating after being identified as a contact of a case Imperial’s modelling ‘pessimistic scenarios’ which assume a three-year average duration of infection-induced immunity Does not consider any variants of concern beyond Delta Peaks occurring in October to December instead of August to October Highest levels seen in Step 4 Roadmap scenarios Will not be reached without waning immunity or a novel variant emerging Behaviour was assumed to be consistent across age groups If those at higher risk of morbidity and mortality from COVID-19 take greater precautions, levels of hospital admissions and deaths could be lower than those seen in the Roadmap modelling Vaccine effectiveness estimates continue to be refined There is now evidence of waning vaccine effectiveness particularly 140 days after the second dose Those individuals vaccinated in late 2020 and early 2021 will have less protection in the coming months Third doses and booster vaccinations, which are able to reverse waning of protection, will limit the impact of waning immunity Policy clarification Third doses for all over 50 or at increased risk UK Chief Medical Officers, advised vaccination aged 12 to 15 If acute COVID-19 combines with other pressures Long COVID Other infectious diseases, influenza, RSV, norovirus Co-infection of SARS-CoV-2 with other diseases Medium-term projections and scenarios They are neither forecasts nor pre Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 2 min

    PCR tests, false positives

    Link to original video, https://www.youtube.com/watch?v=UScNk39xUTk Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 1 hr 6 min

    Profiteering from Catastrophe

    With Professor Paul Goddard. This link will take you to Profiteering From Doom on Amazon https://www.amazon.co.uk/dp/B0FWRRWTRH and this will take you to Profiteering From Doom on Shopify: https://www.clinicalpress.co.uk/products/profiteering-from-doom-just-follow-the-money www.clinical press.co.uk takes you to The Death Science on Shopify and the customer clicks on Shop for Books for all the other books For the guitars try: https://drjazzguitars.com Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 26 min

    Monkeypox, emerging data

    UK monkeypox data, As of 4 August 2022, Uploaded 08-08-22 https://www.gov.uk/government/news/monkeypox-cases-confirmed-in-england-latest-updates Confirmed cases, 2,768 Highly probable, 91 In England, 2,730 A high proportion of cases in London Was 75% Latest, 66% Monkeypox outbreak: epidemiological overview https://www.gov.uk/government/publications/monkeypox-outbreak-epidemiological-overview https://www.gov.uk/government/publications/monkeypox-outbreak-epidemiological-overview/monkeypox-outbreak-epidemiological-overview-5-august-2022 2018 to 2021 7 cases of monkeypox in the UK Rare and Imported Pathogens Laboratory (RIPL) Some NHS laboratories now testing, orthopox polymerase chain reaction (PCR) test Monkeypox outbreak: technical briefing 5 5th August https://www.gov.uk/government/publications/monkeypox-outbreak-technical-briefings https://www.gov.uk/government/publications/monkeypox-outbreak-technical-briefings/investigation-into-monkeypox-outbreak-in-england-technical-briefing-5 Over the past couple of weeks there has been approximately no change in the daily number of confirmed cases. Ascertainment Testing is freely available, it is likely that there is under ascertainment Atypical symptoms, single or scarce lesions, international reports of subclinical infection Level 2 is defined as transmission within a defined sub-population, currently gay, bisexual and men who have sex with men (GBMSM) connected by sexual networks. Data does not suggest a change in case mix (703 out of 2,638) 22 women with confirmed or highly probable monkeypox in England No robust evidence of sustained transmission outside some sexual networks of GBMSM Route of transmission Primary reported route is through close or sexual contact, monkeypox virus has been detected in air and environmental samples in the hospital room of infected patients. No confirmed instances of airborne transmission Limited household transmission has been described in the UK Small numbers with no known route of acquisition, (due to no sex or other potential exposures during incubation period) Assessment (confidence): transmitting primarily through close or sexual contact (moderate). Observed clinical severity No reported deaths in the UK Significant morbidity, severe pain, secondary bacterial infection Virological characterisation UK genomic data is now available. Mostly distinct lineage B.1 Has 61 mutations of unknown significance Two UK cases and some international cases, lineage A.2 No clear-cut evidence of adaptation for improved human transmission. Assessment (confidence): insufficient data. Metrics GBMSM, 95.3% History of STI in past year, 53.9% One or no sexual partners in past 3 months, 13.9% Ten + sexual partners in past 3 months, 30.4% Living with HIV, 26% https://monkeypoxreport.ecdc.europa.eu Cases, 15,926, from 38 countries, European region Laboratory confirmed, 15,524 West African clade, 203 (limited sequencing) Earliest date of symptom, 11 March 2022 Male, 99.1% HIV-positive, 36% Presentation Presented with a rash (9,126 / 9,626) 94.8% Systemic symptoms Such as fever, fatigue, muscle pain, chills, or headache (6,300 / 9, 626) 65% Hospitalised 399 (5.6%), of which 150 cases required clinical care. Three cases Admitted to ICU, 3 (1 unrelated) Two other cases admitted to ICU died of monkeypox Cases reported in health workers, 41 No occupational exposure Dear Secretary of State https://www.tht.org.uk/sites/default/files/2022-08/LGBT%20political%20groups%20letter%20on%20monkeypox%20August%202022_0.pdf Without urgent action, we risk monkeypox becoming endemic in the UK. GBMSM, Messaging must reach communities at high risk of acquiring monkeypox, through targeted messaging on apps, online and in the queer media. Vaccinating those most at risk of monkeypox must be a priority if we are to st Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 14 min

    Mass fatalities

    Mass Fatality Resilience Capability-Lot 2 Uploaded 27-08-25 https://www.contractsfinder.service.gov.uk/Notice/6bc9c974-d864-4f8f-9d02-024c03ea6d49 In the event of a major incident resulting in a large number of fatalities which could overwhelm existing body storage capacity the Home Office would provide contingency support to the requesting local authority. Our core requirement of storage for up to 700 fatalities across three phases Soft Shell Minimum call-off storage of 100 fatalities Deployable within twenty-four hours. Hard Shell They should provide storage of up to 150 of the deceased (including bariatric). Delivery and assembly should take no longer than three days. Temporary Building Alternative building/ structure They should allow both refrigeration and freezing. At least 450 fatalities including bariatric and/ or fragmented fatalities. (deaths caused by flying debris or fragments, or sites here and there) This will need to be deployed within 5 days. Mass Fatalities Resilience Capability-Lot 3 https://www.contractsfinder.service.gov.uk/notice/b9f763dc-ecf2-4af5-ae82-d1f4470c09ce?origin=SearchResults&p=1 In the event of a major incident resulting in a large number of fatalities which could overwhelm existing body storage capacity the Home Office would provide contingency support to the requesting local authority. National Risk Register 2025 https://www.gov.uk/government/publications/national-risk-register-2025 89 risks across 9 themes Hostile state, conventional attack Chemical, Biological, Radiological and Nuclear (CBRN) attacks Nuclear miscalculation Domestic nuclear Massive civil unrest Balkanisation Psychopathic manipulation, internal and external Fifth column Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 21 min

    Yellow card myocarditis advisory

    Yellow card scheme, Don’t wait for someone else to report it https://www.gov.uk/drug-safety-update/yellow-card-please-help-to-reverse-the-decline-in-reporting-of-suspected-adverse-drug-reactions It is estimated that only 10% of serious reactions and between 2 and 4% of non-serious reactions are reported. Yellow card government site, just a click away https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting As of 23 November 2022, (UK) Pfizer/BioNTech, monovalent and bivalent 177,925 Yellow Cards have been reported AstraZeneca 246,866 have been reported Moderna, monovalent and bivalent 47,045 have been reported Novavax 52 reports Brand of vaccine was not specified 2,130 reports Total reports 474,018 Overall reporting rate Around 2 to 5 Yellow Cards per 1,000 doses administered In the 28 days Pfizer/BioNTech, + 2,499 reports AstraZeneca, + 228 Moderna, + 1,099 Novavax, + 15 Brand not specified, + 154 For all COVID-19 vaccines injection-site reactions (sore arm for example) generalised symptoms such as ‘flu-like’ illness headache, chills, fatigue (tiredness), nausea (feeling sick), fever, dizziness, weakness, aching muscles, rapid heartbeat they may be reported more frequently in younger adults Overall, our advice remains that the benefits of the vaccines outweigh the risks in the majority of people. The benefits of the vaccines in preventing COVID-19 and serious complications associated with COVID-19 far outweigh any currently known side effects in the majority of patients. https://wchh.onlinelibrary.wiley.com/doi/pdf/10.1002/psb.1789 Google YT guidelines https://support.google.com/youtube/answer/9891785 Claims that an approved COVID-19 vaccine will cause death, infertility, miscarriage, autism, or contraction of other infectious diseases https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/information-for-healthcare-professionals-on-covid-19-vaccine-moderna 4.4 Special warnings and precautions for use Hypersensitivity and anaphylaxis Anaphylaxis has been reported in individuals who have received Spikevax. Close observation for at least 15 minutes is recommended following vaccination. Myocarditis and pericarditis There is an increased risk for myocarditis and pericarditis following vaccination with Spikevax. Few days, primarily occurred within 14 days, more often after the second dose, more often in younger males risk profile appears to be similar for the second and the third dose Available data suggest that the course of myocarditis and pericarditis following vaccination is not different from myocarditis or pericarditis in general. Healthcare professionals should be alert to the signs and symptoms of myocarditis and pericarditis. Vaccinated individuals should be instructed to seek immediate medical attention if they develop symptoms indicative of myocarditis or pericarditis, such as (acute or persisting) chest pain, shortness of breath or palpitations following vaccination. Healthcare professionals should consult guidance and/or specialists to diagnose and treat this condition. Who can get a COVID-19 vaccine https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/ Everyone aged 5 (on or before 31 August 2022) and over can get a 1st and 2nd dose of the COVID-19 vaccine. People aged 16 and over, and some children aged 12 to 15, can also get a booster dose. Hypertension after COVID-19 vaccination https://pubmed.ncbi.nlm.nih.gov/34985455/ Italian research Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 45 min

    Making America Healthy

    With Consultant Cardiologist, Dr. Aseem Malhotra, Uploaded 01-09-25 First do on Pharm, https://nopharmfilm.com/ https://www.imdb.com/title/tt33511587/ Aseem's work site, https://draseemmalhotra.co.uk/ Hope Accord link, https://thehopeaccord.org http://drjohncampbell.co.uk/C.mp4 Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 20 min

    Hospitals to stop testing for asymptomatic admissions

    Link to free download of John’s 2 textbooks Uploaded 24-08-22 http://159.69.48.3 (please cut and past this address into search engine and it will work) UK Zoe data https://health-study.joinzoe.com New symptomatic cases per day, 108,841 Current symptomatic prevalence, 1,659,056 UK, ONS latest, 24th August https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights UK viral positive prevalence 2.63% in England (1 in 40 people) 2.39% in Wales (1 in 40 people) 2.00% in Northern Ireland (1 in 50 people) 3.12% in Scotland (1 in 30 people) Risk of reinfection Five times higher in the period when the Omicron variants common (20 December 2021 and onwards), compared with the period when the Delta variant common (17 May to 19 December 2021) Risk of reinfection in earlier Omicron period, (March 2022) people were 10 times more likely to be reinfected Overall UK hospital admissions with covid Percentage of patients in acute hospitals with confirmed COVID-19 who are being treated primarily for COVID-19 UK official data https://coronavirus.data.gov.uk US variants nowcast https://covid.cdc.gov/covid-data-tracker/#variant-proportions BA.5 88.9% BA.4.6 6.3% BA.4 4.3% BA.2 0% BA.1s 0% Delta 0% US data, over past two weeks https://www.nytimes.com/interactive/2021/us/covid-cases-deaths-tracker.html Cases, down 16% (almost all states) Test positivity, at 15% down slightly Hospitalizations, down 8% (down in about half of the states) Deaths, down 5% (below 500 per day) Dr. Anthony Fauci (81) https://www.reuters.com/world/us/fauci-step-down-president-bidens-chief-medical-adviser-2022-08-22/ Stepping down in December Director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), (since 1984) part of the National Institutes of Health (NIH) Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 21 min

    Radiation risk to Europe

    And how to protect yourself and family Uploaded 09-08-22 Existential threat to Europe Strikes close to a storage facility for spent fuel Iodine-127, good Iodine-131, very radioactive Iodine-131 (half life 8 days) Caesium-137 (half life 20 years) Uranium 235 (reactor-grade uranium), half life 700 million years https://www.energy.gov/ne/nuclear-fuel-facts-uranium Largest nuclear power plant in Europe, 6 reactors, at Zaporizhzhia https://world-nuclear.org/information-library/safety-and-security/safety-of-plants/chernobyl-accident.aspx Chernobyl 4 reactor accident in 1986 was the result of a flawed reactor design that was operated with inadequately trained personnel. The resulting steam explosion and fires released at least 5% of the radioactive reactor core into the environment, Reactor core had 192 tonnes of fuel, with the deposition of radioactive materials in many parts of Europe. Some 350,000 people were evacuated as a result of the accident Five million people lived in areas of Belarus, Russia and Ukraine contaminated A total of 29,400 km2 was contaminated above 180 kBq/m2. Some 20,000 to 600,000 liquidators irradiated On 24 February Ukraine informed the International Atomic Energy Agency that Russian forces had taken control of all facilities at Chernobyl On 9 March the Chernobyl nuclear plant was disconnected from the electricity grid. National atlas of Ukraine http://wdc.org.ua/atlas/en/4080100.html North, east, and south, easterly and southeasterly winds prevail 1385 miles Acute radiation syndrome (ARS), nausea, vomiting, headaches, burns, fever Longer term effects What to Know About Potassium Iodide for Nuclear Radiation Emergencies https://www.webmd.com/first-aid/potassium-iodide-radiation One 130-milligram pill of potassium iodide https://www.cdc.gov/nceh/radiation/emergencies/ki.htm Do not take KI unless you are instructed by public health or emergency response officials or a healthcare provider. Unstoppable wind of radioactive contamination https://www.telegraph.co.uk/world-news/2022/08/08/unstoppable-radioactive-wind-could-spread-europe-russia-bombards/ Valery Vasiliev, Russian Major General (since been deleted Telegram) there will be either Russian land or a scorched desert https://www.iaea.org Update 88 – IAEA Director General Statement on Situation in Ukraine https://www.iaea.org/newscenter/pressreleases/update-88-iaea-director-general-statement-on-situation-in-ukraine Ukraine’s Zaporizhzya Nuclear Power Plant (ZNPP) International Atomic Energy Agency (IAEA) needs to send a mission IAEA has received information about shelling near the spent fuel storage facility. Friday’s events had breached several of the seven indispensable nuclear safety and security pillars Pillar 1 (Physical integrity) Pillar 2 (All safety and security systems and equipment must be functional at all times) Pillar 3 (Operating Staff) Pillar 4 (Power supply) Pillar 6 (Radiation monitoring and Emergency Preparedness and Response arrangements) Director General Grossi Alarmed by Shelling at Ukraine NPP, says IAEA Mission Vital for Nuclear Safety and Security https://www.iaea.org/newscenter/pressreleases/director-general-grossi-alarmed-by-shelling-at-ukraine-npp-says-iaea-mission-vital-for-nuclear-safety-and-security Director General of the International Atomic Energy Agency (IAEA) Rafael Mariano Grossi I’m extremely concerned by the shelling yesterday at Europe’s largest nuclear power plant, which underlines the very real risk of a nuclear disaster that could threaten public health and the environment in Ukraine and beyond. Any military firepower directed at or from the facility would amount to playing with fire, with potentially catastrophic consequences. This must stop and stop now. I have been ready to lead a mission of IAEA safety, security and safeguards experts to the country’ Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 1 hr 2 min

    Amputation post-vaccination

    Tickets for event 2 June in Glasgow https://tickets-scotland.com/brin X Twitter link for Alex, https://twitter.com/ake2306 Bring on the noise podcasts on Spotify https://spotify.link/SA55n9tjuJb Twitter - https://x.com/BringTheNoise_X?t=k1-QbSa16D4GbTcMFr6pug&s=09 Instagram - https://www.instagram.com/bring_the_noise_podcast?igsh=NWtnMXE4dWI1NnIx Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 14 min

    My yellow card dispatch

    Yellow card scheme, Don’t wait for someone else to report it https://www.gov.uk/drug-safety-update/yellow-card-please-help-to-reverse-the-decline-in-reporting-of-suspected-adverse-drug-reactions It is estimated that only 10% of serious reactions and between 2 and 4% of non-serious reactions are reported. Yellow card government site, just a click away https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting Learn more about your ad choices. Visit megaphone.fm/adchoices

Showing 441–460 of 790 episodes